Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

122.88
+1.891.56%
Post-market: 122.880.00000.00%19:30 EDT
Volume:27.57K
Turnover:3.37M
Market Cap:554.19M
PE:6.37
High:123.25
Open:120.60
Low:120.60
Close:120.99
52wk High:131.68
52wk Low:92.10
Shares:4.51M
Float Shares:4.51M
Volume Ratio:0.76
T/O Rate:0.61%
Dividend:1.13
Dividend Rate:0.92%
EPS(TTM):19.29
EPS(LYR):21.73
ROE:23.89%
ROA:0.60%
PB:1.66
PE(LYR):5.65

Loading ...

Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone

Reuters
·
Yesterday

Eli Lilly price target lowered to $1,341 from $1,344 at BofA

TIPRANKS
·
Yesterday

Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity

THOMSON REUTERS
·
Yesterday

Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine

THOMSON REUTERS
·
Yesterday

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Advance Understanding of the Interconnected Immune and Metabolic Biology in Adults with Psoriasis and Obesity

THOMSON REUTERS
·
Yesterday

Sino Biopharmaceutical Stock Falls 1.4% in Hong Kong

Dow Jones
·
Yesterday

Top 3 Biotech Stocks To Watch In October 2026

Simply Wall St.
·
Yesterday

Citi Lowers Novo Nordisk Price Target to DKK 296: Oral Weight-Loss Pill Sales Outlook Improves, but Margin Growth Remains Weak

Deep News
·
Yesterday

Amgen (AMGN) In Focus As MariTide Buzz Tests Whether The Stock Is Fully Valued

Simply Wall St.
·
Yesterday

What Do Johnson & Johnson (JNJ) Trial Wins Mean For Its Drug Pipeline?

Simply Wall St.
·
Yesterday

Edwards Lifesciences Corp. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Yesterday

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Lilly’s Oral Orforglipron Trial Targets Early Obesity Risks, Raising the Stakes in Weight-Loss Pharma

TIPRANKS
·
Yesterday

AbbVie Targets Jawline and Neck Aesthetics With New Botox and Juvéderm Study

TIPRANKS
·
Yesterday

Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial

TIPRANKS
·
Yesterday

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Yesterday

Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson

Dow Jones
·
Oct 08

AbbVie (ABBV) Lands Two FDA Breakthrough Tags For Temab A In Cancer

Simply Wall St.
·
Oct 08

1s Could Offer Unexpected Relief from Back and Knee Pain, but Doctors Urge Caution

Dow Jones
·
Oct 08

Amgen Stock Forecast: Pipeline Wins Strengthen Growth Story as MariTide Phase 3 Advances

TradingKey
·
Oct 08